首頁 › 子宮頸癌 › 阿拉巴馬州 › Birmingham
Birmingham, AL 的 子宮頸癌 臨床試驗
8 項針對 子宮頸癌 的研究正在 Birmingham（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
招募中2 期
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital, Birmingham
DESTINY-PANTUMOUR04
招募中觀察性研究
- Research Site, Birmingham
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
招募中3 期
- University of Alabama- Birmingham ( Site 5015), Birmingham
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
招募中1 期
- University of Alabama Birmingham, Birmingham
Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
招募中歡迎健康志工
- University of Alabama at Birmingham Cancer Center, Birmingham
A Clinical Trial to Assess PVX7 Immunotherapy Regimens in Advanced Cervical Cancer Patients
招募中1 期
- The University of Alabama at Birmingham, Birmingham
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
招募中
- Cahaba Medical Care - West End, Birmingham
- Cahaba Medical Care - Ensley, Birmingham
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Birmingham
其他城市的 子宮頸癌 試驗
- Houston, TX34 項研究
- Nashville, TN19 項研究
- New York City, NY19 項研究
- Boston, MA18 項研究
- Arlington, VA16 項研究
- Los Angeles, CA16 項研究
- San Antonio, TX14 項研究
- Dallas, TX13 項研究
- St. Louis, MO13 項研究
- Orlando, FL12 項研究
- Chicago, IL12 項研究
- Columbus, OH11 項研究
Birmingham 的其他研究
- 癌症（所有類型）31 項研究
- 乳癌24 項研究
- 卵巢癌23 項研究
- 肥胖症23 項研究
- 非小細胞肺癌22 項研究
- 急性髓系白血病21 項研究
- 多發性骨髓瘤18 項研究
- 慢性阻塞性肺病17 項研究
- 心血管疾病17 項研究
- 第二型糖尿病16 項研究
- 子宮內膜癌16 項研究
- 過重16 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。